Search details
1.
Genomics to select treatment for patients with metastatic breast cancer.
Nature
; 610(7931): 343-348, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36071165
2.
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.
Lancet
; 401(10379): 821-832, 2023 03 11.
Article
in English
| MEDLINE | ID: mdl-36774933
3.
CaboCombo: a prospective, phase IV study of first-line cabozantinib + nivolumab for advanced renal cell carcinoma.
Future Oncol
; 20(13): 811-819, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-37403652
4.
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
Future Oncol
; 2024 Apr 29.
Article
in English
| MEDLINE | ID: mdl-38682560
5.
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 24(8): 881-891, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37451291
6.
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 24(11): 1252-1265, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37844597
7.
Controlling the G-Quadruplex Topology: Toward the Formation of a Lipid Thrombin Binding Aptamer Prodrug.
Bioconjug Chem
; 34(7): 1198-1204, 2023 07 19.
Article
in English
| MEDLINE | ID: mdl-37341722
8.
Light-modulation of gel stiffness: a glyconucleoside based bolaamphiphile as a photo-cleavable low molecular weight gelator.
Soft Matter
; 19(36): 6867-6870, 2023 Sep 20.
Article
in English
| MEDLINE | ID: mdl-37646228
9.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35390339
10.
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
Int J Cancer
; 151(8): 1335-1344, 2022 10 15.
Article
in English
| MEDLINE | ID: mdl-35603906
11.
Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.
Cancer
; 128(11): 2085-2097, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35383908
12.
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.
Oncologist
; 27(10): e783-e795, 2022 10 01.
Article
in English
| MEDLINE | ID: mdl-36124924
13.
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
Oncologist
; 27(12): 1041-1047, 2022 12 09.
Article
in English
| MEDLINE | ID: mdl-35979929
14.
Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective study.
Support Care Cancer
; 30(8): 6583-6591, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35484315
15.
COVID-19 in Patients with Cancer: A Retrospective Study of 212 Cases from a French SARS-CoV-2 Cluster During the First Wave of the COVID-19 Pandemic.
Oncologist
; 26(9): e1656-e1659, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34028132
16.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 378(14): 1277-1290, 2018 Apr 05.
Article
in English
| MEDLINE | ID: mdl-29562145
17.
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).
BMC Cancer
; 21(1): 1292, 2021 Dec 02.
Article
in English
| MEDLINE | ID: mdl-34856936
18.
Self-Assembly of Nucleoside-Derived Low-Molecular-Weight Gelators: A Thermodynamics and Kinetics Study on Different Length Scales.
Langmuir
; 37(1): 297-310, 2021 01 12.
Article
in English
| MEDLINE | ID: mdl-33350837
19.
Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro.
Nanomedicine
; 36: 102429, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34174419
20.
Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Int J Cancer
; 146(8): 2255-2267, 2020 04 15.
Article
in English
| MEDLINE | ID: mdl-31489619